Characterization of methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), two novel positive allosteric modulators of the GABAB receptor (Articolo in rivista)

Type
Label
  • Characterization of methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), two novel positive allosteric modulators of the GABAB receptor (Articolo in rivista) (literal)
Anno
  • 2012-01-01T00:00:00+01:00 (literal)
Alternative label
  • Castelli M.P., Casu A., Casti P., Lobina C., Carai M.A.M., Colombo G., Solinas M., Giunta D., Mugnaini C., Pasquini S., Tafi A., Brogi S., Gessa G.L., Corelli F (2012)
    Characterization of methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), two novel positive allosteric modulators of the GABAB receptor
    in The journal of pharmacology and experimental therapeutics (Online)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Castelli M.P., Casu A., Casti P., Lobina C., Carai M.A.M., Colombo G., Solinas M., Giunta D., Mugnaini C., Pasquini S., Tafi A., Brogi S., Gessa G.L., Corelli F (literal)
Pagina inizio
  • 529 (literal)
Pagina fine
  • 538 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 340 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
  • 10 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 3 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Department of Neuroscience \"Bernard B.Brodie\", University of Cagliari, Cagliari, Italy; Tourette Syndrome Center, University of Cagliari, Cagliari, Italy; Center of Excellence for the Neurobiology of Addictions, University of Cagliari, Cagliari, Italy; Neuroscience Institute, National Research Council of Italy, Section of Cagliari, Italy; Department of Pharmaceutical and Applied Chemistry, University of Siena, Siena, Italy; Porto Conte Research Center, Alghero, Italy; Biomolecular Chemistry Institute, National Research Council of Italy, Section of Sassari, Italy (literal)
Titolo
  • Characterization of methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), two novel positive allosteric modulators of the GABAB receptor (literal)
Abstract
  • The potential efficacy of GABAB receptor agonists in the treatment of pain, drug addiction, epilepsy, cognitive dysfunctions, and anxiety disorders is supported by extensive preclinical and clinical evidence. However, the numerous side effects produced by the GABAB receptor agonist, baclofen, considerably limit the therapeutic use of this compound. The identification of positive allosteric modulators (PAMs) of the GABAB receptor (GABAB PAMs) may constitute a novel approach in the pharmacological manipulation of the GABAB receptor leading to fewer side effects. The present study reports the identification of two novel compounds, methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), that act as GABAB PAMs in (a) rat cortical membranes, and (b) in vivo assay. Both compounds potentiated GABA- and baclofen-stimulated guanosine 5'-O-(3-[35S]thio)-triphosphate ([35S]GTP?S) binding to native GABAB receptors, whilst producing no effect when given alone. GABA concentration-response curves in the presence of fixed concentrations of COR627 and COR628 revealed an increase of potency of GABA rather than its maximal efficacy. In radioligand binding experiments (displacement of the GABAB receptor antagonist, [3H]CGP54626), both COR627 and COR628 increased the affinity of high- and low-affinity binding sites for GABA, producing no effect when administered alone up to a concentration of 1 mM. In vivo experiments indicated that pretreatment with per se ineffective doses of COR627 and COR628 potentiated the sedative/hypnotic effect of baclofen. In conclusion, COR627 and COR628 may represent two additional tools for use in investigating the roles and functions of positive allosteric modulatory binding sites of the GABAB receptor. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it